Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,535
Closed -$87.8K 1008
2025
Q4
$87.8K Buy
35,535
+15,795
+80% +$37.6K ﹤0.01% 916
2025
Q3
$44K Hold
19,740
﹤0.01% 803
2025
Q2
$47.6K Hold
19,740
﹤0.01% 598
2025
Q1
$46K Sell
19,740
-33,290
-63% -$66.6K ﹤0.01% 643
2024
Q4
$98.1K Buy
+53,030
New +$117K ﹤0.01% 611

Other funds holding ABEV

Marex Group's ABEV Position: Q1 2026 in Review

Marex Group sold out of Ambev (ABEV) in Q1 2026, closing a stake of 35,535 shares — an estimated $87.8K sold.

Marex Group first reported a position in ABEV in Q4 2024 and held it in 5 quarters. The position peaked at $98.1K in Q4 2024. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Marex Group reported no remaining Ambev position as of Q1 2026 after selling out during the quarter.
  • Marex Group sold 35,535 Ambev shares in Q1 2026, an estimated $87.8K.
  • Marex Group first reported a position in Ambev in Q4 2024 and held it in 5 quarters.
  • Marex Group's Ambev position peaked at $98.1K in Q4 2024.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.